A range of studies are described examining the responses to blockade of the renin
angiotensin system with angiotensin converting enzyme inhibition in patients with heart …

OBJECTIVE--To compare the first dose responses to low dose angiotensin converting
enzyme inhibitors (captopril, enalapril, and perindopril) in elderly patients with stable chronic …

Angiotensin-converting enzyme (ACE) inhibitors prevent the formation of angiotensin II in
the circulation and a range of tissues. ACE inhibitors not only are effective, well-tolerated …

Angiotensin converting enzyme (ACE) inhibitors are the only therapeutic agents used in the
treatment of chronic heart failure that have been shown to both improve symptoms and …

The renin-angiotensin system plays a pivotal role in the pathophysiology of heart failure.
ACE inhibitors block the production of angiotensin II and are efficacious in the therapy of …

We previously demonstrated differing blood pressure (BP) responses to the first dose of
angiotensin-converting enzyme (ACE) inhibitors in congestive heart failure (CHF). We …

Angiotensin-converting enzyme (ACE) inhibitors improve survival in heart failure and delay
progression to clinical heart failure in patients with left ventricular dysfunction after …

Angiotensin-converting enzyme (ACE) inhibitors have been found effective in the treatment
of congestive heart failure (CHF) and have been recommended as the first choice of …

Angiotensin-converting enzyme (ACE) inhibitors favorably modify control mechanisms that
are disturbed in hypertension and congestive heart failure, principally, but perhaps not …

OBJECTIVE--Comparison of the first dose responses to low dose constant rate infusions of
diacid angiotensin converting enzyme (ACE) inhibitors. DESIGN--Double blind, randomised …